397 related articles for article (PubMed ID: 22062200)
1. Left ventricular assist device driveline infections.
Pereda D; Conte JV
Cardiol Clin; 2011 Nov; 29(4):515-27. PubMed ID: 22062200
[TBL] [Abstract][Full Text] [Related]
2. Current concepts in the diagnosis and management of left ventricular assist device infections.
Nienaber J; Wilhelm MP; Sohail MR
Expert Rev Anti Infect Ther; 2013 Feb; 11(2):201-10. PubMed ID: 23409825
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular assist device-associated infections.
Califano S; Pagani FD; Malani PN
Infect Dis Clin North Am; 2012 Mar; 26(1):77-87. PubMed ID: 22284377
[TBL] [Abstract][Full Text] [Related]
4. Special Treatment and Wound Care of the Driveline Exit Site after Left Ventricular Assist Device Implantation.
Menon AK; Baranski SK; Unterkofler J; Autschbach R; Moza AK; Goetzenich A; Tewarie L
Thorac Cardiovasc Surg; 2015 Dec; 63(8):670-4. PubMed ID: 26177225
[TBL] [Abstract][Full Text] [Related]
5. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
[TBL] [Abstract][Full Text] [Related]
6. Driveline insulation as a conduit for left ventricular assist device pocket infection.
Pinninti M; Thohan V; Sulemanjee NZ
J Thorac Cardiovasc Surg; 2014 Jul; 148(1):e135-6. PubMed ID: 24755334
[No Abstract] [Full Text] [Related]
7. Treatment of HeartMate III-LVAD driveline infection by negative pressure wound therapy: Result of our case series.
Cikirikcioglu M; Ponchant K; Murith N; Meyer P; Yilmaz N; Huber C
Int J Artif Organs; 2021 Nov; 44(11):912-916. PubMed ID: 34558333
[TBL] [Abstract][Full Text] [Related]
8. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support.
Zierer A; Melby SJ; Voeller RK; Guthrie TJ; Ewald GA; Shelton K; Pasque MK; Moon MR; Damiano RJ; Moazami N
Ann Thorac Surg; 2007 Aug; 84(2):515-20. PubMed ID: 17643627
[TBL] [Abstract][Full Text] [Related]
9. Driveline infections in patients supported with a HeartMate II: incidence, aetiology and outcome.
Bomholt T; Moser C; Sander K; Boesgaard S; Køber L; Olsen PS; Hansen PB; Mortensen SA; Gustafsson F
Scand Cardiovasc J; 2011 Oct; 45(5):273-8. PubMed ID: 21539474
[TBL] [Abstract][Full Text] [Related]
10. New Treatment for Driveline Infection Following Implantation of a Ventricular Assist Device.
Sezai A; Unosawa S; Taoka M; Osaka S; Kitazumi Y; Suzuki K; Nakai T; Tanaka M
Heart Surg Forum; 2020 Mar; 23(2):E132-E134. PubMed ID: 32364899
[TBL] [Abstract][Full Text] [Related]
11. Surgical infection prophylaxis for left ventricular assist device implantation.
Walker PC; DePestel DD; Miles NA; Malani PN
J Card Surg; 2011 Jul; 26(4):440-3. PubMed ID: 21554393
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular assist device-related infection: treatment and outcome.
Simon D; Fischer S; Grossman A; Downer C; Hota B; Heroux A; Trenholme G
Clin Infect Dis; 2005 Apr; 40(8):1108-15. PubMed ID: 15791509
[TBL] [Abstract][Full Text] [Related]
13. Multidrug-Resistant Organism Infections in Patients with Left Ventricular Assist Devices.
Donahey EE; Polly DM; Vega JD; Lyon M; Butler J; Nguyen D; Pekarek A; Wittersheim K; Kilgo P; Paciullo CA
Tex Heart Inst J; 2015 Dec; 42(6):522-7. PubMed ID: 26664303
[TBL] [Abstract][Full Text] [Related]
14. Role of Gallium-SPECT-CT in the Management of Patients With Ventricular Assist Device-Specific Percutaneous Driveline Infection.
Kimura Y; Seguchi O; Mochizuki H; Iwasaki K; Toda K; Kumai Y; Kuroda K; Nakajima S; Tateishi E; Watanabe T; Matsumoto Y; Fukushima S; Kiso K; Yanase M; Fujita T; Kobayashi J; Fukushima N
J Card Fail; 2019 Oct; 25(10):795-802. PubMed ID: 31454687
[TBL] [Abstract][Full Text] [Related]
15. Contributory Role of Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis and Clinical Management of Infections in Patients Supported With a Continuous-Flow Left Ventricular Assist Device.
Dell'Aquila AM; Mastrobuoni S; Alles S; Wenning C; Henryk W; Schneider SR; Deschka H; Sindermann JR; Scherer M
Ann Thorac Surg; 2016 Jan; 101(1):87-94; discussion 94. PubMed ID: 26433521
[TBL] [Abstract][Full Text] [Related]
16. Treatment of ventricular assist device driveline infection with vacuum-assisted closure system.
Yuh DD; Albaugh M; Ullrich S; Conte JV
Ann Thorac Surg; 2005 Oct; 80(4):1493-5. PubMed ID: 16181898
[TBL] [Abstract][Full Text] [Related]
17. A retrospective study of left ventricular assist device-related infections.
Bentz B; Hupcey JE; Polomano RC; Boehmer JP
J Cardiovasc Manag; 2004; 15(1):9-16. PubMed ID: 14976692
[TBL] [Abstract][Full Text] [Related]
18. A review of infections in patients with left ventricular assist devices: prevention, diagnosis and management.
Trachtenberg BH; Cordero-Reyes A; Elias B; Loebe M
Methodist Debakey Cardiovasc J; 2015; 11(1):28-32. PubMed ID: 25793027
[TBL] [Abstract][Full Text] [Related]
19. Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary.
Stulak JM; Maltais S; Cowger J; Joyce LD; Daly RC; Park SJ; Aaronson KD; Pagani FD
ASAIO J; 2013; 59(6):570-4. PubMed ID: 24172262
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Success With Driveline Exit Site Relocation for Deep Driveline Infection in Left Ventricular Assist Device Patients.
Balsam LB; Jacoby A; Louie E; Levine JP
Innovations (Phila); 2017; 12(6):440-445. PubMed ID: 29232297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
